Federated Hermes
TXMD icon

Federated Hermes’s TherapeuticsMD TXMD Stock Holding History

Federated Hermes’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,274
Closed -$3.77M – 2176
2015
Q4 		$3.77M Hold
7,274
– – 0.01% 651
2015
Q3 		$2.13M Buy
+7,274
New +$2.59M 0.01% 831

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Federated Hermes's TXMD Position: Q1 2016 in Review

Federated Hermes sold out of TherapeuticsMD (TXMD) in Q1 2016, closing a stake of 7,274 shares — an estimated $3.77M sold.

Federated Hermes first reported a position in TXMD in Q3 2015 and held it in 2 quarters. The position peaked at $3.77M in Q4 2015. 128 funds tracked by Wall St. Rank hold TXMD as of Q1 2016.

  • Federated Hermes reported no remaining TherapeuticsMD position as of Q1 2016 after selling out during the quarter.
  • Federated Hermes sold 7,274 TherapeuticsMD shares in Q1 2016, an estimated $3.77M.
  • Federated Hermes first reported a position in TherapeuticsMD in Q3 2015 and held it in 2 quarters.
  • Federated Hermes's TherapeuticsMD position peaked at $3.77M in Q4 2015.
  • 128 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2016.

Based on Federated Hermes's 13F filing for Q1 2016, filed 11 May 2016.